High Rate of Falsified Cancer Drugs in African Countries
High Rate of Falsified Cancer Drugs in African Countries
Approximately 17% of cancer drugs in Ethiopia, Kenya, Malawi, and Cameroon were found to be substandard or falsified, risking ineffective treatment and tumor progression. The study highlights regulatory challenges, need for improved testing, and the importance of stronger oversight in Africa. WHO is working to address the issue.
